IgG2 F(c) Recombinant Rabbit mAb: Fc Engineering Strategies for Enhanced Assay Performance
Why Choose the IgG2 Subtype as the Fc Backbone for Recombinant Rabbit Monoclonal Antibodies
Immunoglobulin G is the most common antibody subtype in therapeutic antibody development and basic immunoassay work. Among the four IgG subclasses, IgG2 is often regarded as an inert backbone. This reputation stems from its distinctive disulfide bond arrangement and relatively weak Fcγ receptor binding. In recombinant rabbit monoclonal antibody design, however, this characteristic constitutes a strategic advantage. Rabbit-derived monoclonal antibodies combine higher affinity with broader epitope recognition than mouse-derived antibodies. Their native Fc segment, however, is poorly compatible with the human complement and Fc receptor systems.
Achieving Molecular Structural Stability in IgG2 Fc Recombinant Rabbit Monoclonal Antibodies
The stability of a recombinant antibody depends on precise pairing of hinge region disulfide bonds and complete folding of the domains. The IgG2 subclass contains a distinctive hinge structure. It has more interchain disulfide bonds in the heavy chain than IgG1 and exists in two disulfide bond isomer forms designated A and B. During recombinant rabbit monoclonal antibody construction, the constant region sequence must fully preserve the native conformation of human IgG2. This avoids aggregation or incomplete folding caused by heterologous assembly.
Studies show that fusing the rabbit-derived variable region by gene synthesis to the human CH1-hinge-CH2-CH3 domains achieves high expression of correctly assembled molecules in mammalian cells. Optimization of the signal peptide and expression vector further improves yield. In addition, the integrity of hinge region Cys residues is critical for IgG2 isomer equilibrium. If hinge region reduction or mispairing occurs, it directly affects the antigen neutralization capacity of the antibody molecule. The expression system must therefore maintain a mildly oxidizing environment to promote natural disulfide bond formation. For specific application scenarios, site-directed mutagenesis can introduce additional disulfide bonds or stabilize the hinge conformation to further improve molecular homogeneity.
How IgG2 Fc Glycosylation Affects Recombinant Rabbit Monoclonal Antibody Function
The Fc segment N-glycan structure is an important element regulating antibody conformation and receptor recognition. IgG2 Fc retains the conserved N-glycosylation site at Asn297, and its oligosaccharide core consists of GlcNAc and mannose, typically with terminal fucose and a small amount of galactose. Compared with IgG1, IgG2 Fc glycan chains show lower terminal sialylation, a feature that further weakens binding to FcγR. In recombinant rabbit monoclonal antibodies, glycoform distribution is significantly affected by host cell line, culture conditions, and purification process.
If defucosylation modification is applied, the weak interaction between the antibody and FcγRIIIa can be enhanced while maintaining the low effector activity of IgG2. This improves sensitivity in certain detection systems. However, glycan deletion or excessive trimming induces Fc conformational changes that reduce the thermal stability of the CH2 domain. Glycosylation engineering therefore requires precise regulation according to the final use of the antibody. In immunoassay scenarios where non-specific binding must be minimized, retaining the native human IgG2 glycan profile is the most prudent strategy.
Can the IgG2 Fc of Recombinant Rabbit Monoclonal Antibodies Optimize Antigen Binding Activity
Although the Fc segment does not directly participate in antigen recognition, its conformational stability can indirectly affect Fab segment orientation and freedom of movement. Because of its relatively rigid hinge, the IgG2 subclass shows a smaller Fab swing amplitude. This may reduce affinity when recognizing certain antigen epitopes with greater steric hindrance. To address this, researchers have attempted to introduce a flexible linker peptide between CH1 and the hinge to restore Fab arm rotational capacity.
In addition, IgG2 Fc itself can form a self-aggregation tendency through intramolecular hydrophobic interactions, which may increase the functional affinity, or avidity, of the antibody at low concentration. In recombinant rabbit monoclonal antibodies, moderate retention of this property helps improve immunocapture efficiency. However, excessive self-aggregation raises non-specific background and must be avoided by screening mutants or adjusting buffer composition. The IgG2 Fc is thus not merely a structural scaffold but an active module that can reverse-regulate antigen binding function through engineering modification.
Unique Application-Level Advantages of IgG2 Fc Recombinant Rabbit Monoclonal Antibodies
In detection platforms such as immunohistochemistry and flow cytometry, non-specific signal is the primary factor interfering with result interpretation. IgG2 Fc recombinant rabbit monoclonal antibodies, through their low Fc receptor affinity, can significantly reduce background binding to FcγR-expressing stromal cells or blood cells. In double-antibody sandwich detection systems, such antibodies can reduce Fc segment cross-recognition between capture and detection antibodies, thereby improving signal-to-noise ratio. For in vivo tracing studies, IgG2 Fc does not readily activate complement or recruit natural killer cells. This property helps restore the true distribution dynamics of antigen under physiological conditions.
Notably, the intrinsically higher dissociation temperature and acid stability of rabbit monoclonal antibodies allow them to maintain structural integrity even under stringent elution conditions. This forms a synergistic effect with the stronger conformational rigidity of IgG2 Fc. This class of recombinant antibodies therefore shows good adaptability in emerging technical paths. These include multiplex staining, automated staining platforms, and microfluidic chip detection.
Product Focus: Human IgG2 F(c) Recombinant Rabbit mAb
The Human IgG2 F(c) Recombinant Rabbit mAb (S0B0223) is a monoclonal antibody product with high specificity, high affinity, and excellent stability. It was developed specifically against the conserved conformational epitope of the human immunoglobulin G2 Fc segment. It specifically recognizes the IgG2 subtype, with very low cross-reactivity against IgG1, IgG3, and IgG4, as well as IgA and IgM. It is a key subtype discrimination tool for antibody drug development, immunoassay method establishment, serological typing research, and diagnostic reagent development.
| Core Advantage | Detailed Description |
|---|---|
| High-specificity IgG2 subtype recognition | Through precise antigen design and epitope screening, this product specifically targets the conformational epitope of the human IgG2 Fc segment. It has been verified to show very low cross-reactivity with human IgG1, IgG3, and IgG4 and other immunoglobulin subtypes, ensuring precise detection of human IgG2 in complex biological samples such as serum, cell supernatant, and polyclonal antibody mixtures. It is an ideal tool for subtype-specific analysis. |
| Outstanding affinity and sensitivity | Developed on a recombinant rabbit monoclonal antibody platform, the antibody has intrinsic high affinity, verified by SPR and BLI with KD values reaching the nanomolar range, and achieves high-sensitivity detection across ELISA, Western Blot, immunodiffusion, and liquid chip platforms. |
| Multi-platform applicability | Validated for multiple immunoassay platforms, including ELISA for capture and detection, Western Blot under non-reducing conditions, immunoturbidimetry, and surface plasmon resonance, and can be flexibly applied to quantitative and qualitative IgG2 analysis in different experimental scenarios. |
| Excellent stability and batch-to-batch consistency | Produced in a recombinant expression system, the product shows highly consistent performance between batches and excellent physicochemical stability, providing stable and reliable raw material support for large-scale diagnostic reagent production, long-term research projects, and multi-center clinical sample analysis. |
| Suitable for multiple critical application scenarios | Antibody drug subtype identification and quality control for subtype confirmation, Fc segment integrity analysis, and in-process intermediate quality control during process development of IgG2 subtype therapeutic antibodies. Serological detection and immunotyping as a core pairing raw material for developing human IgG2 subtype-specific ELISA quantification kits and immunonephelometric or immunoturbidimetric reagents, supporting humoral immune status assessment in immunodeficiency, autoimmune disease, and infectious disease. Polyclonal antibody drug component analysis for IgG2 subtype content determination and batch consistency evaluation in polyclonal antibody drugs containing IgG2 components, such as intravenous human immunoglobulin. |
Detailed technical documentation is available. It includes subtype specificity validation data with cross-reactivity analysis against IgG1, IgG3, and IgG4. Multi-platform application recommendations covering ELISA pairing and Western Blot conditions are also provided, together with affinity constants and typical application cases. A mature rabbit immunization and single B cell antibody platform covers antigen design, immunization optimization, high-throughput single B cell sorting, gene cloning, and recombinant expression. For more details on the Human IgG2 F(c) Recombinant Rabbit mAb (S0B0223), to obtain validation data, or to request a sample test, please contact us. All products are intended for basic research use only.
Related Products
| Catalog No. | Product Name | Target | Specificity | Recommended Application |
|---|---|---|---|---|
| S0B0223 | Human IgG2 F(c) Recombinant Rabbit mAb (SDT-318-75) | Human IgG2 F(c) | IgG2 subtype specific | ELISA, WB, Immunoturbidimetry, SPR |
| S0B0223P | Human IgG2 F(c) Recombinant Rabbit mAb, PBS Only (SDT-318-75) | Human IgG2 F(c) | IgG2 subtype specific, PBS buffer | ELISA, WB, Immunoturbidimetry, SPR |
ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs
At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Starter, Absin, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.
Disclaimer
This article was partially created with the assistance of artificial intelligence. If any content involves copyright or intellectual property issues, please inform us, and we promise to verify and remove it immediately.
